Expand Content

View Cancer Clinical Trials

3164   |  
Cytokine Induced Gene Expression

Advanced Disease
Main Campus

Contact Information
Cancer Answer Line


8:00 am - 4:30 pm, Monday - Friday

  1. Primary
    • To obtain data for the genes induced by interferons (IFNs), chemotherapy drugs, and cytokines in tumor cells and immune cells in cancer patients and healthy volunteers.
    • To ascertain differing patterns of gene and tumor response that occur with different interferons, cytokines and chemotherapy drugs.

Inclusion Criteria
  1. Patients must have a clinical and/or a histological diagnosis of malignancy.
  2. Age ≥ 18 years
  3. All patients must be informed of the investigational nature of this study and must provide written informed consent in accordance with institutional and federal guidelines.

Exclusion Criteria
  1. Patients who are known to be HIV, or HBsAg positive.
  2. No patient may have a second malignancy other than the following exceptions:
    • Basal cell carcinoma ofthe skin.
    • Carcinoma in-situ of the uterine cervix.
    • Any malignancy treated with curative intent and in complete remission for ≥ 3 years.

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2015 Cleveland Clinic. All rights reserved.